Pdp (68071 3298 03 A86)
Doxazosin Tablet
Product Images NDC 68071-3298
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-3298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Doxazosin-structure.jpg (Doxazosin Structure)
Figure1.jpg (Figure1)
Table3.jpg (Table3)
This is a summary of data obtained from controlled trials comparing the effectiveness of placebo with doxazosin, a medication used to treat benign prostatic hyperplasia (BPH). The data includes maximum flow rate, symptom score rate, and mean baseline change in several different studies. In Study 2, the modified Boyarsky questionnaire was used to analyze change in the fixed-dose efficacy phase, 2-6 hours post-dose.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
